Showing results (521-530 of 536) with videos related to

Sort By:
Pageof 54
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 18, 2010
Targeting drug-metabolizing enzymes for effective chemoprevention and chemotherapyHollie I Swanson, Vincent C O Njar, Zhen Yu, et al.
International Journal of Biological Sciences|May 20, 2026
Synonymous editing alters ion channel function, favoring prime editing for retinal disease correctionMeha Kabra, Mariya Moosajee, Ana Navarrete, et al.
Frontiers in Disaster and Emergency Medicine|April 3, 2026
Training for pediatric cannot intubate cannot oxygenate: surgical airway should replace needle cricothyrotomyAllison M B Lehman, Paul Amstutz, Jackson E Moore, et al.
Oncogene|February 6, 2026
Disruption of androgen receptor-cofactor interactions by the RNA-binding protein FUS/TLS alters androgen signalling in prostate cancerG N Brooke, D A Leach, R L Culley, et al.
Biorxiv : the Preprint Server for Biology|February 8, 2024
Human IL-6 fosters long-term engraftment of patient derived disease-driving myeloma cells in immunodeficient miceZainul S Hasanali, Alfred L Garfall, Lisa Burzenski, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 29, 2005
Cancer chemotherapy and drug metabolismDavid S Riddick, Chunja Lee, Shairoz Ramji, et al.
JCI Insight|May 7, 2024
Human IL-6 fosters long-term engraftment of patient-derived disease-driving myeloma cells in immunodeficient miceZainul S Hasanali, Alfred L Garfall, Lisa Burzenski, et al.
Endocrine Reviews|October 26, 2010
Child health, developmental plasticity, and epigenetic programmingZ Hochberg, R Feil, M Constancia, et al.
Acta Pharmaceutica Sinica. B|April 8, 2017
Regulation of drug metabolism and toxicity by multiple factors of genetics, epigenetics, lncRNAs, gut microbiota, and diseases: a meeting report of the 21st International Symposium on Microsomes and Drug Oxidations (MDO)Ai-Ming Yu, Magnus Ingelman-Sundberg, Nathan J Cherrington, et al.
Gene Therapy|January 14, 2005
Inhibiting estrogen responses in breast cancer cells using a fusion protein encoding estrogen receptor-alpha and the transcriptional repressor PLZFL Buluwela, J Pike, D Mazhar, et al.
Pageof 54